Enchem (348370) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
The company specializes in electrolytes and additives for secondary batteries, with a global supply network and production bases in Korea, China, the US, and Europe. Its main business is supplying electrolytes for EVs, ESS, and IT/mobile batteries, with ongoing expansion into recycling and new materials.
As of June 30, 2026, the company operates 14 consolidated subsidiaries and has recently expanded through new investments and joint ventures.
Financial highlights
Consolidated revenue for H1 2026 was KRW 186.4 billion, down from KRW 312.8 billion in FY2025 and KRW 365.7 billion in FY2024.
Operating loss for H1 2026 was KRW -35.8 billion, compared to KRW -78.4 billion in FY2025 and KRW -50.4 billion in FY2024.
Net loss for H1 2026 was KRW -39.2 billion, following KRW -70.6 billion in FY2025 and KRW -558.3 billion in FY2024.
Cash and cash equivalents at H1 2026 end were KRW 6.1 billion, down from KRW 12.1 billion at FY2025 end.
Equity at H1 2026 end was KRW 446.9 billion, with total assets of KRW 1,061.6 billion.
Outlook and guidance
Management is pursuing external investment, asset sales, and expects improved cash flow from growing North American demand.
Liquidity risk is considered manageable, but there is material uncertainty regarding going concern due to recurring losses and current liabilities exceeding current assets by KRW 259.1 billion.
Latest events from Enchem
- H1 2024 saw a sharp revenue drop and large net loss amid global expansion and new investments.348370
Q2 2024 - 2024 Q3 saw steep revenue decline and heavy net loss, but global expansion and R&D continue.348370
Q3 2024 - Q1 2025 saw a sharp revenue drop but strong net profit from non-operating gains.348370
Q1 2025 - Net profit returned to positive despite lower sales, with global expansion and R&D ongoing.348370
Q3 2025 - 2023 saw a sharp swing to net loss on lower sales and higher costs, despite global expansion.348370
Q4 2025 - 2024 saw a steep revenue drop, heavy net loss, and major impairments amid persistent market risks.348370
Q4 2024 - Revenue declined and operating loss posted, but net profit achieved via non-operating gains.348370
Q2 2025